Evofem Biosciences (NASDAQ:EVFM) Stock Price Passes Above 50 Day Moving Average – Time to Sell?

Evofem Biosciences, Inc. (NASDAQ:EVFMGet Free Report)’s stock price crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $0.01 and traded as high as $0.01. Evofem Biosciences shares last traded at $0.01, with a volume of 234,744 shares.

Evofem Biosciences Trading Up 4.2 %

The company has a 50 day moving average of $0.01 and a 200-day moving average of $0.01. The firm has a market capitalization of $1.13 million, a P/E ratio of -0.02 and a beta of -0.90.

About Evofem Biosciences

(Get Free Report)

Evofem Biosciences, Inc, a biopharmaceutical company, develops and commercializes various products to address unmet needs in women's sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women, and EVO200 for the prevention of recurrent bacterial vaginosis.

Featured Stories

Receive News & Ratings for Evofem Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evofem Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.